BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891]
URL: https://www.wjgnet.com/1007-9327/full/v13/i36/4891.htm
Number Citing Articles
Ji Young Lee, Seong Hyun Kim, Yong Hwan Jeon, Jongmee Lee, Min Ju Kim, Dongil Choi, Won Jae Lee. Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular CarcinomaJournal of Computer Assisted Tomography 2010; 34(1): 127 doi: 10.1097/RCT.0b013e3181b1587a
Christina Heilmaier, Amelie M. Lutz, Nicolae Bolog, Dominik Weishaupt, Burkhardt Seifert, Jürgen K. Willmann. Focal Liver Lesions: Detection and Characterization at Double-Contrast Liver MR Imaging with Ferucarbotran and Gadobutrol versus Single-Contrast Liver MR ImagingRadiology 2009; 253(3): 724 doi: 10.1148/radiol.2533090161